KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Discontinued OperationsCash from Discontinued OperationsCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Change in Inventory (2016 - 2022)

TherapeuticsMD filings provide 12 years of Change in Inventory readings, the most recent being $551000.0 for Q3 2022.

  • On a quarterly basis, Change in Inventory rose 49.73% to $551000.0 in Q3 2022 year-over-year; TTM through Sep 2022 was -$588000.0, a 2000.0% decrease, with the full-year FY2021 number at $711000.0, down 78.69% from a year prior.
  • Change in Inventory hit $551000.0 in Q3 2022 for TherapeuticsMD, up from -$2.8 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $3.0 million in Q3 2019 to a low of -$2.8 million in Q2 2022.
  • Median Change in Inventory over the past 5 years was $497644.0 (2018), compared with a mean of $714490.1.
  • Biggest five-year swings in Change in Inventory: skyrocketed 1145.66% in 2019 and later plummeted 1335.53% in 2022.
  • TherapeuticsMD's Change in Inventory stood at $889449.0 in 2018, then soared by 49.29% to $1.3 million in 2019, then crashed by 136.07% to -$479000.0 in 2020, then surged by 154.28% to $260000.0 in 2021, then skyrocketed by 111.92% to $551000.0 in 2022.
  • The last three reported values for Change in Inventory were $551000.0 (Q3 2022), -$2.8 million (Q2 2022), and $1.4 million (Q1 2022) per Business Quant data.